DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.65 (2019) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/1057

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_65_p122.pdf177.83 kBAdobe PDFダウンロード
タイトル: Investigation of thyroid cancer cases that were not detected in the Thyroid Ultrasound Examination program of the Fukushima Health Management Survey but diagnosed at Fukushima Medical University Hospital
著者: Yokoya, Susumu
Iwadate, Manabu
Shimura, Hiroki
Suzuki, Satoru
Matsuzuka, Takashi
Suzuki, Satoshi
Murono, Shigeyuki
Yasumura, Seiji
Kamiya, Kenji
Hashimoto, Yuko
Suzuki, Shin-Ichi
学内所属: 甲状腺・内分泌診療センター
甲状腺内分泌学講座
放射線医学県民健康管理センター
臨床検査医学講座
耳鼻咽喉科学講座
公衆衛生学講座
病理病態診断学講座
誌名/書名: Fukushima Journal of Medical Science
巻: 65
号: 3
開始ページ: 122
終了ページ: 127
発行日: 2019年
抄録: The Great East Japan Earthquake, which occurred on March 11, 2011, and its subsequent Fukushima Daiichi Nuclear Power Plant accident, prompted implementation of the Thyroid Ultrasound Examination (TUE) program as a part of the Fukushima Health Management Survey. The purpose of this program is to support residents of Fukushima Prefecture, and to analyze the health effects of the released radionuclides. Regardless of relatively high participation rates and a well-planned diagnostic flow, it is conceivable that not all thyroid cancer cases can be detected by the TUE program. The aims of the present study were to identify and characterize these "outside" cases, targeting patients at Fukushima Medical University (FMU) Hospital. As of June 30, 2017, we have successfully identified 11 outside cases. These corresponded to 5.7% of the 194 subjects who were identified as having thyroid cancer or suspected thyroid cancer in the TUE program. Although the outside subjects of other institutes were not investigated, the present study may have identified the majority of outside subjects in Japan, considering that FMU Hospital treats a large number of thyroid cancer subjects. Furthermore, the characteristics of the 11 subjects were not different from those of the subjects identified in the TUE program. These findings confirm that the TUE program was able to identify subjects of thyroid cancer adequately and sufficiently.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/1057
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/1057/1/FksmJMedSci_65_p122.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2019-26
PubMed番号: 31839647
関連ページ: https://doi.org/10.5387/fms.2019-26
権利情報: © 2019 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.65 (2019)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_65_p122.pdf177.83 kBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard